Skip to main content
Mohammad Telfah, MD, Internal Medicine, Westwood, KS

MohammadAli MahmoudTelfahMD

Internal Medicine Westwood, KS

Hospital Medicine/Hospitalist

Physician

Dr. Telfah is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Telfah's full profile

Already have an account?

  • Office

    2330 Shawnee Mission Parkway
    Suite 210
    Westwood, KS 66205
    Phone+1 913-588-0348
    Fax+1 913-588-4085

Education & Training

  • University of Iowa
    University of IowaM.S., Clinical Investigation, 2017
  • Rochester Regional Health/Unity Hospital (Rochester)
    Rochester Regional Health/Unity Hospital (Rochester)Residency, Internal Medicine, 2012 - 2015
  • Jordan University of Science and Technology FOM
    Jordan University of Science and Technology FOMClass of 2010

Certifications & Licensure

  • IA State Medical License
    IA State Medical License 2015 - 2022
  • KS State Medical License
    KS State Medical License 2018 - 2021

Awards, Honors, & Recognition

  • Best Medical Documentation Award UIHC Hospitalist Program, 2017
  • Residency Program Medical Jeopardy Winner 2014
  • Resident of the Month for Two Consecutive Months 2013
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Hydration, methylene blue, and thiamine as a prevention regimen for ifosfamide-induced encephalopathy  
    Gharaibeh EZ., Telfah M., Powers BC., Salacz ME., J Oncol Pharm Pract, 1/1/2018
  • Utilization of 4T score to determine the pretest probability of heparin-induced thrombocytopenia in a community hospital in upstate New York  
    Samhouri, Y., Telfah M., Kouides R., Woodlock T., J Community Hosp Intern Med Perspect, 1/1/2016

Books/Book Chapters

Abstracts/Posters

  • Older Patients with NPM1 Mutated AML Have Distinctive Genomic Mutation Landscape Associated with Enrichment in Immunosuppressive Gene Signature
    Mohammad Telfah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • In-house next generation sequencing (NGS) panel to measure the frequency of recurrent genetic mutations in newly diagnosed AML patients: A single institution experience.
    Telfah, M., Gharaibeh, E., Balmaceda, N., Abdelhakim, H., Godwin, A., Pessetto, Z., Lin,T., KUCC Research Symposium, Overland Park, KS, 1/1/2018
  • A Rare Cause of Anemia: 74-year-old male with high-grade neuroendocrine tumor of the colon.
    Balmaceda, N., Telfah, M., Al-Kasspooles, M., Dai, H., Neupane, P., Baranda, J., Kansas Chapter of the American Collage of Physician, Lenexa, KS, 1/1/2018
  • Join now to see all

Lectures

  • The prognosis of NF1 mutations in newly diagnosed AML: A single-center retrospective study. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Abiraterone acetate in comparison to enzalutamide in African American patients with metastatic castrate-resistant prostate cancer: A single-center retrospective study. 
    2019 ASCO Annual Meeting - 6/1/2019
  • A window of opportunity trial of atorvastatin in p53-mutant and p53 wild type malignancies. 
    2019 ASCO Annual Meeting - 6/1/2019

Other